Padma Kadiyala
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Genetics top 5%
- Biomedical Engineering top 10%
- Co-authors
- Pedro R. LöwensteinMaría G. CastroRobert DohertyNeha KamranJoerg LahannJason V. GregoryErkki RuoslahtiMelissa Cadena
- Topics
- Glioma Diagnosis and Treatment (15 papers)Immune cells in cancer (13 papers)Cancer Immunotherapy and Biomarkers (6 papers)
- Cited by
- GeneticsImmunologyBiomaterials
- Journals
- Nature CommunicationsThe Journal of Experimental MedicineSHILAP Revista de lepidopterología
- Partner nations
- United StatesArgentinaAustralia
In The Last Decade
Padma Kadiyala
37 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 446
- Immunology 425
- Oncology 303
- Genetics 273
- Biomedical Engineering 269
Countries citing papers authored by Padma Kadiyala
This map shows the geographic impact of Padma Kadiyala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padma Kadiyala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padma Kadiyala more than expected).
Fields of papers citing papers by Padma Kadiyala
This network shows the impact of papers produced by Padma Kadiyala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padma Kadiyala. The network helps show where Padma Kadiyala may publish in the future.
Co-authorship network of co-authors of Padma Kadiyala
This figure shows the co-authorship network connecting the top 25 collaborators of Padma Kadiyala. A scholar is included among the top collaborators of Padma Kadiyala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Padma Kadiyala. Padma Kadiyala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | Arginase 1 is a key driver of immune suppression in pancreatic cancerbreakdown → | 96 |
| 5 | 35 | |
| 6 | 3 | |
| 7 | 16 | |
| 8 | 38 | |
| 9 | 19 | |
| 10 | 17 | |
| 11 | 64 | |
| 12 | 212 | |
| 13 | 6 | |
| 14 | 5 | |
| 15 | 7 | |
| 16 | 5 | |
| 17 | 1 | |
| 18 | 125 | |
| 19 | 38 | |
| 20 | 1 |
About Padma Kadiyala
Padma Kadiyala is a scholar working on Genetics, Immunology and Cancer Research, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Immune cells in cancer (13 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Genetics (273 citations), Immunology (425 citations) and Biomaterials (188 citations). Padma Kadiyala has collaborated with scholars based in United States, Argentina and Australia. Frequent co-authors include Pedro R. Löwenstein, María G. Castro, Robert Doherty, Neha Kamran, Joerg Lahann, Jason V. Gregory, Erkki Ruoslahti, Melissa Cadena, Anna Schwendeman and James J. Moon. Their work appears in journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.